Condition

Inpatients

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting1

Common interventions5

Lead sponsors shown4

Clinical trials

4 shown

Flumazenil for Benzodiazepine Reversal in Electroconvulsive TherapyNCT07619092 · 2026-01-15

RECRUITING

A Trial of Extended Reality Activities to Enhance Leisure Participation Among Inpatients With Persistent Mental Health ConditionsNCT06964477 · 2025-07-01

NOT_YET_RECRUITING

Inpatient Group Acceptance and Commitment Therapy (ACT) for Psychosis Spectrum DisorderNCT06086184 · 2023-10-16

UNKNOWN

An Educational Intervention to Improve Disease Management Knowledge of Hospitalized Patients With COPDNCT03323190 · 2016-08-30

WITHDRAWN

Common interventions

ACT group therapyBEHAVIORAL1 Electroconvulsive therapy (ECT)PROCEDURE1 FlumazenilDRUG1 Inpatient COPD educationBEHAVIORAL1 XR-Based Leisure InterventionBEHAVIORAL1

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

flumazenil1

Leading sponsors

Anders Jørgensen 1 Chia-Hui Hung 1 Rush University Medical Center 1 Vivantes Netzwerk für Gesundheit GmbH 1

Trial status mix

NOT_YET_RECRUITING1

RECRUITING1

UNKNOWN1

WITHDRAWN1

Phase mix

NA4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.